Novartis Pharmaceuticals Corp. et al.; Withdrawal of Approval of 27 New Drug Applications and 58 Abbreviated New Drug Applications; Correction

Summary

The FDA is correcting a notice that withdrew approval of 27 new drug applications and 58 abbreviated new drug applications from multiple applicants, after excluding a footnote in the table in the original document published on July 21, 2010.